Citi Raises SpaceX Price Target to $240

October 21, 2026 Analyst: John Godyn 1 min read Reproduced verbatim
Rating
Buy
Target
$240
from $200 (+20%)
Upside
+51%
SPCX at $159 today
Citi and SpaceX logos

What the analyst said

Citi analyst John Godyn raised the price target on SpaceX (NASDAQ: SPCX) to $240 (from $200) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

SPCX trades at $159. The 30 analysts who set a target in the last 3 months range from $75 to $800, with a median of $233. This $240 target is 3% above the median.

12-month window: day 0 of 365, closes on October 21, 2027.

Track record

This callOpen: a 12-month target, scored on October 21, 2027, a year after the note.

Firm track recordCiti: 86% of its 22 targets at least a year old were reached within 12 months (#10 of 28 firms). Accuracy ranking →

Earnings reactionOne of 19 notes after SpaceX’s Oct 20 results: 9 of 19 raised targets. See every call →

Citi on SpaceX

Citi price targets on SpaceX

2 calls from July 7, 2026 to October 21, 2026. The target went from $200 to $240 (+20%). The rating stayed Buy.

Citi targetSPCX share price
  1. October 21, 2026 This noteTarget raised from $200 (+20%)Buy$240
  2. July 7, 2026Earliest call shownBuy$200
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.